BSX vs PLUS · P/E 20, rev $16.75B vs P/E 17, rev $2.07B
Boston Scientific Corp (BSX) versus ePlus inc (PLUS) — a side-by-side from cached financials, not a winner call.
Boston Scientific Corp (BSX) is a medical devices company listed on US.
ePlus inc (PLUS) is a software - application company listed on NASDAQ.
Latest reported BSX revenue for 2024-12-31 was $16.75B. Net income was $1.85B. Revenue was up 17.6% from 2023-12-31 to 2024-12-31. BSX currently screens at market cap $71.81B and trailing P/E 20.2.
Latest reported PLUS revenue for 2025-03-31 was $2.07B. Net income was $108.0M. Revenue was down 7.0% from 2024-03-31 to 2025-03-31. PLUS currently screens at market cap $2.10B and trailing P/E 17.1.
BSX currently screens at market cap $71.81B and trailing P/E 20.2. PLUS currently screens at market cap $2.10B and trailing P/E 17.1.
Not investment advice. Open the BSX and PLUS stock pages for the full models.
Not investment advice.